Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
The following comparison illustrates the practical cost difference for a typical patient on a monthly maintenance schedule: For patients with pernicious anemia or severe malabsorption where injections are clinically necessary, this cost is justified and often covered by insurance
As an NNMT inhibitor, its shown promise in models targeting insulin sensitivity, lipid oxidation, and age-related metabolic decline
This typically involves: Intrinsic factor antibodies (highly specific for pernicious anaemia, though sensitivity is only 50%) [12] [28] Gastric parietal cell antibodies (more sensitive but less specific) Coeliac serology if malabsorption is suspected Consideration of upper gastrointestinal endoscopy in selected cases, particularly with autoimmune gastritis/pernicious anaemia NICE guidance emphasises that treatment should not be delayed whilst awaiting antibody results if clinical features strongly suggest deficiency, as irreversible neurological damage can occur
The full capability detail sits in denial management services, and AR follow-up services handle aging denials already in the queue
US$ 29.39
US$ 24.59
US$ 29.36
US$ 26.93
US$ 21.91